StocksAmgen IncAMGN

AMGN

Amgen Inc

242.77 -1.87 (-0.76%)
Precios retrasados ofrecidos por el índice NASDAQ, en USD Mercado cerrado
Invertir
V
242.46
C
242.97

Amgen Inc

Amgen es la mayor empresa de biotecnología del mundo. Produce numerosos productos de éxito como Neupogen y Neulesta que estimulan la producción de células blancas para luchar contra infecciones.
Último mes
35,546
Seguidores
0.45%
Inversores
100% Of them have BUY positions.
An Increase of 0% from last trading Day

Mercados relacionados

Thermo Fisher Scientific Inc
TMO
0.24 (0.05%)
V
464.65
C
465.76
Emergent BioSolutions Inc
EBS
-1.97 (-3.01%)
V
63.37
C
63.54
DaVita HealthCare Partners Inc
DVA
0.47 (0.39%)
V
122.19
C
122.48
Bayer AG
BAYN.DE
0.41 (0.77%)
V
53.48
C
53.59
Smith & Nephew
SN.L
6.50 (0.42%)
V
1548.61
C
1552.40
Ver más

Inversores

Ver más
Destacado
Daniël Lizarazo Fuentes
Editado
With Organon trading at $28.39 (as of writing) I do find that this stock, just like $MRK (Merck) that spun it off, is trading at quite an attractive price point. Using the guidance provided by Organon and other public information some nice surface level numbers roll out: mCap = 7.15 USD B Liabilities... Mostrar más Traducir
Me gusta ComentarCompartir
1 respuesta
null
.
Federico Albamonte
Editado
Despite the success of Biogen and the low exposure that I've mantained in the biotechnology industry in these months, I'm considering to further diminish my exposure to companies which only specializes in the biotech business. Despite the importance of biotech, the relevance of its products... Mostrar más Traducir